September 10, 2026
Next Event

Wemedoo joins discussions on advancing investigator-led research

Investigator-initiated trials play a vital role in advancing medical research, enabling investigators and research institutions to explore innovative treatment approaches and address important unmet medical needs. As these studies continue to grow in complexity, efficient trial management, reliable data oversight, and streamlined collaboration become increasingly important for successful execution.

This year, Wemedoo is looking forward to participating in the Investigator-Initiated Trials Conference, an event dedicated to the opportunities, challenges, and evolving landscape of investigator-led research. The conference brings together experts from across the clinical research ecosystem to share experiences, discuss best practices, and explore strategies for improving study outcomes and operational efficiency.

By bringing together investigators, sponsors, CROs, academic institutions, and technology providers, the event creates a valuable platform for knowledge exchange and meaningful discussions around the future of clinical trials. Topics such as regulatory considerations, study funding, data management, and digital innovation will be at the center of the conversation.

Representing Wemedoo at the event will be Spencer Egan and Jonas Heidenfors, who are looking forward to connecting with industry professionals and discussing how modern clinical trial technology can support more efficient study planning, execution, and oversight.

Whether you'd like to discuss investigator-led research, clinical trial operations, or how oomnia helps organizations streamline trial management and collaboration, we'd be happy to connect and exchange ideas.

Event Details

Event: Investigator-Initiated Trials Conference
Date: September 17-18
Location: Av. Fontes Pereira de Melo, Pç do Marquês de Pombal 8, 1069-310 Lisbon, Portugal
Attendees: Spencer Egan, Jonas Heidenfors
Website: https://twoknctmedia.com/index.php/2026/02/24/investigator-initiated-trials-conference/